A kinome siRNA screen identifies HGS as a potential target for liver cancers with oncogenic mutations in CTNNB1.
about
Wnt Drug Discovery: Weaving Through the Screens, Patents and Clinical Trialsβ-defensin 1 expression in HCV infected liver/liver cancer: an important role in protecting HCV progression and liver cancer developmentUse of HuH6 and other human-derived hepatoma lines for the detection of genotoxins: a new hope for laboratory animals?
P2860
A kinome siRNA screen identifies HGS as a potential target for liver cancers with oncogenic mutations in CTNNB1.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
A kinome siRNA screen identifi ...... oncogenic mutations in CTNNB1.
@ast
A kinome siRNA screen identifi ...... oncogenic mutations in CTNNB1.
@en
type
label
A kinome siRNA screen identifi ...... oncogenic mutations in CTNNB1.
@ast
A kinome siRNA screen identifi ...... oncogenic mutations in CTNNB1.
@en
prefLabel
A kinome siRNA screen identifi ...... oncogenic mutations in CTNNB1.
@ast
A kinome siRNA screen identifi ...... oncogenic mutations in CTNNB1.
@en
P2093
P2860
P1433
P1476
A kinome siRNA screen identifi ...... oncogenic mutations in CTNNB1.
@en
P2093
Aurianne Lescure
Bruno Ragazzon
Christine Perret
Elaine Del Nery
Elodie Anthony
Franck Perez
Frédéric Canal
Jacques Camonis
P2860
P2888
P356
10.1186/S12885-015-2037-8
P407
P50
P577
2015-12-29T00:00:00Z
P5875
P6179
1053173586